LUPIN
|
The Current P/E Ratio of LUPIN is 22.74.
| Share Price | ₹2,323.2 | Feb 26,2026 |
| Market Cap | ₹106,170.2 Cr | |
| Earnings-TTM | ₹4,669.2 Cr | TTM-Consolidated Results |
| Price/Earnings | 22.74x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of LUPIN
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹106,170.2 Cr] as on Feb 26,2026
(/) Earnings [ ₹4,669.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 22.74x ]
Thus, for LUPIN , the investors are currently willing to pay 22.74 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LUPIN !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LUPIN over the last five years.
Historical PE (Price/Earnings) ratio chart of LUPIN
PE Ratio Performance Analysis for LUPIN
- LUPIN 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 34.67x.
- LUPIN 's operated at median p/e ratio of 38.08x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LUPIN 's p/e ratio peaked in Mar2023 at 68.54x.
- LUPIN 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does LUPIN 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| LUPIN | 4,669.18 | 22.74 | 106,170.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 38.92 | 428,185.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 69.29 | 171,766.0 |
| CIPLA LTD | 4,544.70 | 24.13 | 109,680.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 65.55 | 148,923.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.98 | 110,081.0 |
| MANKIND PHARMA LTD | 1,796.65 | 52.39 | 94,121.6 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 19.13 | 94,399.8 |
| AUROBINDO PHARMA LTD | 3,513.20 | 20.20 | 70,974.0 |
| ABBOTT INDIA LTD | 1,524.13 | 36.72 | 55,961.5 |
| ALKEM LABORATORIES LTD | 2,424.46 | 28.36 | 68,758.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LUPIN 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 19.13x |
| Max industry PE | 69.29x |
| Median industry PE | 28.36x |
| Average industry PE | 36.13x |
You may also like the below Video Courses